Chromosomes are primarily analyzed genetically using PCR technology to detect hemophilia.
Hemophilia is an X-linked recessive genetic disease, a group of bleeding disorders with hereditary coagulation disorders that usually develop in males and females are carriers of the causative gene. Due to the genetic defect, the patient’s body lacks coagulation factor VIII or IX, and the coagulation function is impaired.
Hemophilia patients or carriers can be diagnosed through genetic testing, and high-risk groups can take the initiative to receive genetic testing, genetic counseling, prenatal diagnosis and other services before pregnancy and delivery, which can effectively prevent the birth of hemophilia-affected children and block the continued inheritance of hemophilia. In addition to this, diagnosis can also be made through coagulation factor tests or clinical symptoms.
Specific tests and disease diagnosis should be conducted under the guidance of a physician.